Latin America steps towards common medtech market with Mercosur GMP move
This article was originally published in Clinica
Executive Summary
In a significant move for medtech manufacturing across Latin America, the Mercosur trading bloc has approved measures to harmonise the inspection and certification of manufacturers of medical devices and in vitro diagnostics. The bloc’s five member states – Argentina, Brazil, Paraguay, Uruguay and Venezuela – are to transpose a series of good-manufacturing practice (GMP) compliance procedures into national law by the end of April 2013.